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Abstract.  To assess in vivo the postulated participa- 
tion of urokinase-type (u-PA) and tissue-type (t-PA) 
plasminogen activators in processes involving tissue 
remodeling and cell migration, we have studied the 
cellular distribution of u-PA and t-PA mRNAs during 
mouse oogenesis and embryo implantation. By in situ 
hybridizations, we detected t-PA mRNA in oocytes and 
u-PA mRNA in granulosa and thecal cells from 
preovulatory follicles. These findings are compatible 
with a role for plasminogen activators in oogenesis 
and follicular disruption. We demonstrated the pres- 
ence of u-PA mRNA in the invasive and migrating 
trophoblast cells of 5.5- and 6.5-d-old embryos. At 7.5 
days, u-PA mRNA was predominantly localized to 
trophoblast cells that had reached the deep layers of 
the uterine wall, while the peripheral trophoblast cells 
surrounding the presomite stage embryo were devoid 
of specific signal.  In 8.5-d-old embryos abundant u-PA 
mRNA expression resumed transiently in the giant 
trophoblast cells at the periphery of the embryo and in 
the trophoblast cells of the ectoplacental cone, to be- 
come undetectable in  10.5-d-old  embryos. These ob- 
servations establish the in vivo expression of the u-PA 
gene by invading and migrating trophoblast cells in a 
biphasic time pattern; they are in agreement with the 
proposed involvement of the enzyme in the extracellu- 
lar proteolysis accompanying embryo implantation. 
M 
AMMALIAN gametogenesis and embryogenesis are 
associated  with extensive tissue  remodeling and 
cellular migrations.  Such processes require tem- 
porospatially regulated degradation of extracellular matrices 
and experimental evidence has accumulated suggesting that 
extracellular proteases are indeed involved in ovulation (Es- 
pey, 1974; Beers,  1975; Beers et al., 1975), sperm matura- 
tion (Lacroix et al., 1979), fertilization (Stambaugh,  1978; 
Saling, 1981; Bleil et al., 1981; Moiler and Wassarman, 1989), 
and embryo implantation  (Denker,  1972; Stricldand et al., 
1976; Glass et al., 1983). Though the proteases susceptible 
of participating  in these various  conditions  have not been 
fully identified, plasminogen activators (PAs)  j are known to 
be secreted during gametogenesis  (Beers,  1975; Lacroix et 
al., 1981; Huarte et al., 1985, 1987a; Vihko et al., 1989) and 
early embryonic development (Strickland et al., 1976; Marotti 
et al.,  1982; Axelrod, 1985). PAs are serine proteases that 
catalyze the conversion of plasminogen into plasmin, an ac- 
tive protease of broad specificity capable of degrading,  di- 
rectly or indirectly, i.e., through the activation of metallopro- 
tease zymogens, all components of the extracellular matrix 
(Reich, 1978; Dan~ et al., 1985). The two known PAs, uro- 
kinase-type (u-PA) and tissue-type (t-PA) plasminogen acti- 
vators, are the product of two distinct genes; they are synthe- 
1. Abbreviations used in this paper: PA, plasminogen activator; t-PA, tissue- 
type plasminogen activator; u-PA, urokinase-type plasminogen activator. 
sized and secreted by a wide spectrum of cell types and are 
generally thought to play a central role in regulating extracel- 
lular proteolysis in physiological and pathological conditions, 
precisely where tissue disruption and cellular migration are 
prominent (DanO et al., 1985). In the mouse ovary, u-PA is 
produced by granulosa cells under the control of gonadotro- 
pins (Canipari et al., 1987), while t-PA is the first protease 
to have been identified in murine oocytes (l-Iuarte  et al., 1985); 
plasmin-mediated proteolysis facilitates follicular disruption 
(Beers, 1975) and could also be involved in oocyte migration 
in the oviduct. Trophoblasts are the first cell type to differen- 
tiate in mammalian embryos: they are transiently endowed 
with marked invasive and migrating  properties,  to achieve 
embryo implantation via the penetration of the uterine mucosa. 
Cultured mouse blastocysts and trophoblasts have been shown 
to produce PA activity, with a timing that corresponds to the 
period of trophoblastic  invasiveness in vivo (Stricldand et 
al.,  1976). These cumulated observations  suggest that PAs 
may act as catalyzers of the extracelhilar proteolysis accom- 
panying gametogenesis and embryo implantation;  however, 
they are based on in vitro analyses and limited information 
is presently available concerning PA synthesis in vivo. 
This prompted us to perform in situ hybridizations,  using 
specific cRNA probes for mouse u-PA and t-PA mRNAs to 
assess the cellular distribution of PA synthesis during oogen- 
esis and early phases of  embryo implantation. We report here 
that cell types engaged in follicular disruption and in uterine 
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and trophoblast cells, express high levels of u-PA mRNA in 
a  time-dependent fashion compatible with the postulated par- 
ticipation of the PA-plasmin  system in physiological events 
of tissue remodeling and cell migration. 
Materials and Methods 
Materials 
Ovaries were collected  from adult NMRI virgin females (Kleintierfarm 
Mad6ring, Basel); preovulatory  ovaries were obtained from pregnant mare 
serum primed females, injected 46 h later with human chorionic gonadotro- 
pins, and killed 5 h after the last injection (5 IU of pregnant mare serum 
and human chorionic gonadotropins ip/female); postovulatory  ovaries were 
obtained from females similarly treated and killed 16 h after the last injec- 
tion, i.e., ,x,4 h after ovulation. Ovaries were dissected, embedded in Tissue- 
Tek (Miles Ames Div., Elkhart, IN), frozen down in pngx~led methylbutane 
and stored at -70oc. Four to six ovaries were analyzed for each condition. 
Adult NMRI female mice were caged with males in the evening and 
monitored for the appearance of a vaginal plug the following morning. On 
the 4th day of gestation, blastocysts were flushed from the uteri of NMRI 
females with Fll medium supplemented with 5% FCS, and then cultured 
for 4 d in FII medium, supplemented with 10% FCS. At the end of the cul- 
ture, the trophoblast outgrowths were collected and pooled in groups of 10 
embryos before analysis. 
Pregnant mice were sacrificed on the 6th, 7th, 8th, and llth days of gesta- 
tion to obtain 5.5-, 6.5-, 7.5-, 8.5-, and lO.5-d-old embr3~s.  Segments of 
uteri were dissected,  embedded, and stored as above. The presomite stages 
were confirmed histologically  using Theiler's description (1989). 8.5-d-old 
embryos were at the three to seven somites stage and 10.5 d of development 
corresponded to the 28-34 somites stage. For each time point, four to six 
whole embryos were analyzed,  and 10-40 tissue sections were prepared per 
embryo. 
Enzymatic Analyses 
Protein extractions,  immunoprecipitation, gel electrophoresis,  and zymog- 
raphy were performed as described (Huarte et ai.,  1985). 
Plasmid Constructions and In Vitro Transcriptions 
The u-PA antisense probe pSP64-MU containing the 658-bp Pst I-Hind III 
fragment of the mouse u-PA cDNA clone pDB29 (Belin et al.,  1985), the 
u-PA sense probe pSP65-MU containing the same fragment in the opposite 
direction and the t-PA antisense probe pSP64-MT3  containing the 726-bp 
Pvu II-Spe I fragment of the mouse t-PA cDNA clone pUC9-A33 (Rickles 
et al.,  1988) were transcribed in vitro, as previously described (Huarte et 
al., 1987a,b), using SIRi RNA polymerase, in the presence of 12.5/zM of 
t~32p-labeled UTP (400 Ci/mmol; Amersham International, Amersham, 
UK) for Northern blot analyses, or 30/~M 3H-labeled UTP and 30/~M 3H- 
labeled CTP (40 and 20 Ci/mmol, respectively;  Amersham International) 
for in situ hybridizations.  3H-labeled  RNAs  were reduced to an average 
size of 50-100 nt by mild alcaline hydrolysis,  in 50 mM Na2 CO3 for 30 
rain (u-PA probes) or 15 min (t-PA probes) at 50°C,  neutralized with 1 M 
HOAc, extracted in phenol chloroform, precipitated in ethanol, and resus- 
pended in a minimal volume of water. 
Northern Blot Analyses 
Total RNAs from vas deferens,  oviduct, and ovaries were extracted as de- 
scribed elsewhere (Busso et al., 1986). Blastoeyst RNA was prepared as de- 
scribed (Hnarte et al., 1987b). RNAs were denatured with glyoxal, electro- 
phoresed in 1.2% agarose gels, and transferred overnight onto Biodyne nylon 
membranes (Pall  Corp.,  Glen Cove,  NY).  Prehybridizations, hybridiza- 
tions, and posthybridizations washes  were  performed as previously de- 
scribed (Huarte et al.,  1987a,b). 
In Situ Hybridizations 
5-#m cryostat tissue sections were mounted on poly-L-lysine- (Sigma Chemi- 
cal Co., St. Louis, MO) coated microscope slides, fixed in 1% paraformal- 
dehyde in PBS for 1-2 rain, rinsed in PBS, and stored  in 70% ethanol at 
4°C until analyzed.  Fixed sections were rinsed in 2x SSC (ix SSC  =  150 
mM NaC1, 15 mM Na-citrate, pH 7.0), acetylated with 0.25% (vol/vol) ace- 
tic anhydride in 0.1 M triethunolamine, pH 8.0, at room temperature  for 10 
rain, incubated in 0.1 M Tris-hydmchioride,  pH 7.0, 0.1 M glycine at room 
temperature for 30 min, and prehybridiznd in 2x SSC, 50% formamide at 
50°C for 15 min. 10-20 ng of 3H-Inheled RNAs were applied to each sec- 
tion in 20 #1 of hybridization mixture (2x SSC, 50% formamide,  I mg/mi 
BSA (RNAse-free;  Sigma Chemical Co.), 1 mg/ml Escherichia coil rRNA 
(Boehringer Mannheim GmbH, Mannheim, FRG), 10 mM DTr and 5% 
dextran sulfate) at 50°C for 3 h. Slides were subsequemiy  washed in 2x 
SSC, 50% formamide and 0.2x SSC, 50% formamide,  at 50°C for 30 rain 
each. Unhybridized transcripts were digested with 10 #g/mi ribonnclease 
A (u-PA probe) or 5 #g/mi ribonuclease TI (t-PA probe), at 37°C for 30 
min. The slides were washed again in 2x  SSC, 50% formandde at 50°C 
for 15 rain dehydrated in graded ethanol and air-dried. Finally, they were 
imn~rsed in NTB-2 emulsion (Eastman Kodak Co., Rochester, NY), diluted 
1:1 in deionized water. After 4-5 wk exposure,  they were developed in Ko- 
dak D-19 developer,  fixed in 30% Na thiosulfate,  and counterstained  in 
methylene blue. 
Microphotographs were  taken with a  Zeiss photomicroscope (Zeiss, 
Oberkochen, FRG),  equipped  with an immersion dark-field  condensor, 
using Kodak Ektachrome 50 color film. 
Controls of  Specificity 
They were performed as previously  described (Huarte ct al.,  1987a) and 
included the use of sense RNA probes  and dot blot analysis under conditions 
of in situ hybridizations.  As compared to our previous report (Huarte et al., 
1987a), the stringency conditions of hybridizations and posthybridizations 
washes were increased, according to results obtained in preliminary experi- 
ments comparing the signals obtained with the u-PA and t-PA probes on tis- 
sue sections of the vas deferens and the oviduct. These organs have a similar 
anatomical  organization but they contain respectively  and predominantly 
u-PA and t-PA mRNA (see Fig. 3). An optimal distinction between u-PA 
and t-PA mRNAs was achieved by including a wash at low ionic strength 
and RNAse treatments.  In each hybridization, control tissue sections of the 
vas deferens  and the oviduct  were included. 
Results 
t-PA mRNA in Oocytes  and u-PA mRNA in Ovarian 
Granulosa and Thecal Cells 
In ovaries from unstimulated females, t-PA mRNA was de- 
tected in the cytoplasm of a fraction of the oocytes; the posi- 
tively labeled oocytes were observed in medium and large 
size follicles (Fig.  1, A and B).  The distribution of t-PA 
mRNA remained localized to oocytes in preovulatory and 
postovulatory ovaries (not shown), although, as expected, 
the number of large follicles was increased in gonadotropin- 
treated animals. In unstimulated ovaries, moderate amounts 
of u-PA mRNA were confined to the granulosa cells of large 
follicles (not shown). In postovulatory ovaries, the u-PA sig- 
nal was comparable to that obtained in unstimulated ovaries 
and predominantly localized in the outer part of the follicles 
(Fig. 1 C). In preovulatory ovaries, the concentration of u-PA 
mRNA in granulosa cells was greatly increased (Fig.  1 D) 
and, in addition, some thecal cells were also found to express 
abundant u-PA mRNA (Fig. 1 E). The exclusive distribution 
of t-PA mRNA in oocytes and of U-PA mRNA in follicular 
cells corroborated in vitro observations (Huarte et al., 1987b; 
Canipari et al.,  1987) and confirmed the respective speci- 
ficities of the t-PA and u-PA cRNA probes. 
Synthesis of  u-PA by Cultured Trophoblast Cells 
Previous studies have demonstrated the secretion of PA enzy- 
matic activity by cultured mouse trophoblasts (Strickland et 
al.,  1976). However,  the type of PA has not been reported. 
To identify the type of PA produced by trophoblast cells, we 
The Journal of Cell Biology, Volume 109, 1989  2472 Figure 1. Localization of t-PA (A and B) and u-PA mRNA (C, D, and E) by in situ hybridizations of 3H-labeled cRNA probes to frozen 
sections from ovaries. (A, B, and C) Unstimulated ovaries; (D and E) preovulatory ovaries. B, C, and D are darkfield micrographs; A 
and E are light-field micrographs. Note the absence of grains over the oocyte nucleus in ,4 and R  Sections shown in C, D, and E were 
hybridized with the same probe and exposed for the same length of time. Arrowheads in E denote labeled thecal cells. Bar,  10 ~m. 
assayed extracts of isolated trophoblasts from cultured blast- 
ocysts for PA activity and mRNA content. One single type 
of PA was revealed by zymography after SDS-PAGE, and im- 
munoprecipitafion with specific antibodies showed that this 
PA is undistinguishable from the 48,000-Mr u-PA (Fig. 2). 
Preparations of total RNA were analyzed by Northern blot 
hybridizations. The detection of  u-PA mRNA, but not of  t-PA 
mRNA,  confirmed the exclusive synthesis of u-PA by cul- 
tured trophoblast cells (Fig.  3, A and B). 
Localization of u-PA mRNA in Invasive and Migrating 
Trophoblast  Cells 
To localize u-PA and t-PA mRNAs in vivo, we analyzed im- 
planting embryos by in situ hybridizations. In 5.5-d-old era- 
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cells by SDS-PAGE and zymography. Extracts of 10 trophoblast 
outgrowths  were analyzed directly (lane 1) or after immunoprecipi- 
tation with anti-murine u-PA IgG (lane 2) or irrelevant IgG (lane 
3). Eluates of  the S. aureus-bound immune complexes  formed with 
anti-murine u-PA  lgG (lane 4) and irrelevant  IgG (lane 5) were also 
analyzed. Mudne u-PA  standard  (lane 6). The photograph was taken 
after 28 h of incubation at 37°C. 
bryos, trophoblast cells are polyploid, surround the egg cyl- 
inder,  and  also  constitute  the  ectoplacental  cone  which 
projects  above  the  embryonic  pole.  At  that  stage,  u-PA 
mRNA was present in cells recognizable by their morphol- 
ogy and their distribution as the peripheral flattened tropho- 
blasts that have begun to erode the uterine mucosa and as 
ectoplacental cone cells, while the egg cylinder and the de- 
ciduous cells were devoid of specific signal (Fig. 4, A and 
B). In contrast, t-PA mRNA was not detected in any embry- 
onic cell, but in epithelial cells of  the numerous glands located 
at the periphery of the decidual cells (Fig. 4, C and D). t-PA 
has been isolated from uterine tissue (Rijken et al.,  1979; 
Rijken and Collen, 1981) and our results identify the endo- 
metrial glands as the most probable source of the enzyme. 
The distribution of u-PA and t-PA mRNAs in different cell 
types provides an internal control for the specificity of their 
detection; furthermore, no signal was observed when a sense 
u-PA RNA probe was used (not shown). 
During the next day, the trophoblast cells continue to pene- 
trate into the uterine wall and the ectoplacental cone gains 
contact with the mesometrial blood vessels. In 6.5-d-old em- 
bryos, the invasive and migrating trophoblast ceils, identified 
as polyploid cells, contained large amounts of u-PA mRNA, 
while the trophoblasts located at the periphery of the embryo 
showed moderate, albeit significant, labeling. The inspection 
of successive sections showed that the higMy labeled giant 
cells that had infiltrated the uterine mucosa were clearly 
detached from the ectoplacental cone (Fig. 5, A and B); a 
similar intense signal was obtained on individual giant cells 
present at the opposite pole, close to the zone of decaying 
uterine epithelium, suggesting that trophoblasts are migrat- 
ing from both poles of the embryo (Fig. 5,  C and D). The 
majority of  the uterine glandular structures observed at 5.5 d 
were no longer visible and no t-PA mRNA could be detected 
(not shown). 
In 7.5-d-old embryos, a number of trophoblast cells have 
reached the deep layers of the endometrium, whereas a per- 
sistent layer of flattened trophoblasts surrounds the parietal 
endoderm.  At  that  stage,  we  observed  an  intense  u-PA 
mRNA signal in a few isolated giant cells that had penetrated 
into the uterine stroma, while the trophoblast cells surround- 
ing the embryo remained weakly positive or were negative 
(Fig. 5, E and F). Here again, no detectable t-PA mRNA was 
observed (not shown). 
During the next 24 h, the embryo expands considerably 
and in 8.5-d-old embryos, corresponding to the three to seven 
somites stage,  the peripheral  trophoblast cells enlarge to 
form a loose network of cells, attached to the maternal tis- 
sues  and  adherent  to  Reichert's  membrane.  These  giant 
trophoblast cells contained large amounts of u-PA mRNA 
(Fig. 6, A and B), a signal comparable in intensity to that ob- 
served in the ectoplacental trophoblasts at 5.5 and 6.5 d of 
development. High levels of  u-PA mRNA were also observed 
in the ectoplacental cone; though they were of smaller size 
than peripheral trophoblasts, the positively labeled cells had 
prominent nuclei, were localized predominantly at the front 
edge of  the ectoplacental cone, and contained glycogen gran- 
ules, indicating they were trophospongium precursors (Fig. 
6,  C and D). 
Finally, in  10.5-d-old  specimens,  corresponding  to  the 
30-34 somites stage, the giant trophoblast cells surrounding 
the embryo were  not labeled by  the u-PA  cRNA  probe, 
whereas the numerous maternal venous sinuses were lined 
Figure 3.  Northern blot analysis of u-PA (A) and bPA (B) mRNA 
in adult tissues and cultured blastocysts.  2 ~g of  total RNA was pre- 
pared from the following  tissues: vas defetens (lane 1), ovary (lane 
2), and oviduct (lane 3); total  RNA was obtained from 30 primary 
oocytes (lane 4), from the inner cell masses (lane 5), and tropho- 
blast outgrowths (lane 6) of 10 embryos. 
The Journal  of Cell Biology,  Volume 109, 1989  2474 Figure 4. Localization of u-PA mRNA in peripheral and ectoplacental trophoblast cells (A and B) and of t-PA mRNA in the endometrial 
glands (C and D) by in situ hybridizations of 3H-labeled cRNA probes to frozen sections of a gravid uterus containing a 5.5-d-old embryo. 
A and C are light-field micrographs; B and D are the corresponding dark-field micrographs. Bar, 10/~m. 
with cells expressing u-PA mRNA (Fig. 7, A and B'). These 
cells constitute probably the outer layer of  the hemotrichorial 
murine placenta fenders, 1965). Hybridizations with the t-PA 
cRNA probe revealed a weak positive signal over a few cells 
localized in the labyrinth (not shown). The identity of these 
cells cannot be ascertained, but they could represent the em- 
bryonic endothelial cells. 
Discussion 
In mammals, considerable experimental evidence has linked 
production of PAs to normal and pathological conditions in- 
volving tissue destruction and cell migration (Reich, 1978; 
Dane et al.,  1985).  For example, PAs are thought to play a 
role in regulating extracellular proteolysis associated with 
gametogenesis, fertilization, and early embryonic develop- 
ment (Beers,  1975; Lacroix et al.,  1979;  Strickland et al., 
1976; Huarte et al., 1985, 1987a; Vihko et al., 1989).  How- 
ever, most studies have relied on in vitro observations to sub- 
stantiate the potential implications of PAs in physiological 
processes of tissue remodeling. Though a few immunohisto- 
chemical studies on mouse tissue have been reported for 
u-PA  (Larsson et  al.,  1984)  and t-PA  (Kristensen et  al., 
1985), only very limited information concerning the cellular 
sites of PA synthesis in vivo is presently available.  Indeed, 
secondary interactions of these secreted proteins with com- 
ponents of extracellular matrices (Hoylaerts et al.,  1982; 
Salonen et al., 1984),  cell surface receptors (Vassalli et al., 
1985;  Stoppelli et al.,  1985),  or inhibitors (Baker et al., 
1980;  Loskutoff et al.,  1983;  Lecander and Astedt,  1986; 
Wohlwend et al.,  1987) can result in erroneous interpreta- 
tions of results based on their immunological or enzymatic 
localization. By using in situ hybridization, a method that al- 
lows unambiguous identification of potential cellular sites of 
synthesis for a  given protein,  we have localized t-PA and 
u-PA mRNAs in the mouse ovary and implanting embryo. 
t-PA mRNA was present in the cytoplasm of oocytes, in 
agreement with previous biochemical studies showing that 
dormant t-PA mRNA accumulates in growing oocytes and is 
translated in oocytes undergoing meiotic maturation (Huarte 
et  al.,  1987b).  In  contrast,  we  detected u-PA  mRNA  in 
granulosa cells of medium size follicles, confirming recent 
work reporting the production of u-PA by mouse granulosa 
cells in vitro (Canipari et al.,  1987).  We also observed that 
hormonal stimulation increases u-PA mRNA in both granu- 
losa and thecal cells, whereas in the rat, gonadotropins stim- 
ulate production of t-PA by granulosa cells and of u-PA by 
thecal cells (Canipari and Strickland, 1985). The differential 
Sappino et al. Plasminogen Activators in  Tissue  Invasion  2475 Figure 3.  Localization of u-PA mRNA in invasive and migrating tmphoblast cells by in situ hybridization of 3H-labeled cRNA probe to 
frozen sections of 6.5-d-old (.4, B, (7, and D) and 7.5-d-old (E and F) embryos. A, B, D, E, and F are dark-field micrographs; C is the 
corresponding light-field micrograph shown in D. The ectoplacental cone is located on the right in A, B, C, and D, and on the left in E 
and E  A, B, and C correspond to different sections of the same embryo. Bar, 10 pro. 
distribution of u-PA and t-PA synthesis in the mouse ovary 
may be relat~xl to the functional differences attributed to these 
two enzymes, t-PA activity is enlmnced in presence of fibrin 
(l-loylaerts et al.,  1982;  Suenson et al.,  1984), heparin, and 
proteoglycans (Andrade-Gordon and Strickland,  1986), and 
t-PA is produced by endothelial ceils (Levin, 1983; Kristensen 
et al.,  1984).  The primary function of t-PA could thus be to 
catalyze fibrinolysis. In this view, t-PA synthesized and released 
by maturing oocytes might prevent premature clot formation 
in the ovarian stigma and egg adhesion to fibrin deposits in 
the oviduct before implantation (Canipari  and Stricldand, 
1985; Huarte ¢t al.,  1985). In contrast, u-PA catalyzed pro- 
The Journal of Cell Biology,  Volume  109, 1989  2476 Figure 6.  Localization of u-PA mRNA in the trophoblast cells surrounding the embryo (A and B) and in the trophospongial cells of the 
ectoplacental cone (C and D) by in situ hybridizations of 3H-labeled cRNA probe to frozen sections of 8.5-d-old embryos. A and C are 
light-field  micrographs; B and D  are the corresponding darkfield micrographs. Bar,  10 #m. 
teolysis is generally associated with tissue remodeling  and 
cellular migration processes,  including  inflammatory reac- 
tions and organ involutions  (Unkeless et al.,  1974;  Vassalli 
et al.,  1976; Ossowski et al.,  1979).  The high levels of u-PA 
mRNA in granulosa and thecal cells of preovulatory follicles 
are compatible with  the postulated  participation  of the en- 
zyme in follicular remodeling. Indeed, maturing follicles are 
complex structures that display considerable fluctuations in 
Figure 7. Localization of u-PA mRNA in the cells lining venous sinuses, adjacent to the trophoblast cell layer,  by in situ hybridizations 
of 3H-labeled cRNA probe to frozen sections of 10.5-d-old  embryos. A is a light-field  micrograph and B is the corresponding dark-field 
micrograph. Cells lining maternal venous sinuses are labeled (arrowheads), while a large trophoblast cell is devoid of grains. Bar, 10 #m. 
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eration, followed by rupture and complete reorganization af- 
ter ovulation. Our observations support a role for u-PA in the 
focalized extracellular proteolysis required for follicular rup- 
ture and/or  the  redistribution  of  granulosa  and thccal  cells  to 
achieve luteal  differentiation,  and add to the evidence that 
u-PA is  implicated  in  physiological  conditions  characterized 
by hormonally mediated  tissue  remodeling (Ossowski et  al., 
1979). 
Trophoblast cells  exemplify a cell  type capable of  major 
tissue  disruption  (Schlafke  and Enders, 1975);  they  are the 
first  cells  to differentiate  in mammalian embryos and are 
generally  considered  as  playing  a pivotal  role  in  embryo im- 
plantation,  by acquiring  invasive  and migratory properties. 
Cultured trophoblast  cells  are  known to  produce  PA activity, 
during a time period corresponding to their  invasivc  phase 
in utero  (Strickland  et al.,  1976).  However, the type of  PA 
they secrete  had not been characterized;  most importantly, 
numerous cell  lines  produce  PAs in  vitro,  and  it  was  essential 
to  determine whether trophoblast  cells  do  express  PAs genes 
in  vivo.  Our investigations  identify  u-PA as  the  enzyme pro- 
duced  by mouse trophoblast  cells  in  culture  and  establish  the 
synthesis  of  u-PA mRNA  by trophoblast  cells  in  vivo.  From 
fertilization  to day 4 of development, i.e., before implanta- 
tion begins,  the embryos do not contain  detectable  u-PA 
activity (Strickland et al., 1976; Huarte et al., 1985). Tropho- 
blasts display a first wave of high u-PA mRNA content be- 
tween the 5th and 7th days of gestation, corresponding to the 
period when they penetrate the uterine wall. After a transient 
reduction,  u-PA mRNA synthesis resumes in the peripheral 
giant trophoblast cells that surround the embryo at the three 
to seven somites stage; this second wave of u-PA mRNA pro- 
duction is also limited  in time and coincides with a period 
of major embryonic expansion. These findings give support 
to the proposed role for u-PA in tissue remodeling:  they doc- 
ument a developmental  modulation of the u-PA synthetic po- 
tential in a highly invasive and migrating cell type. The syn- 
thesis of u-PA provides trophoblast  cells with an efficient 
mechanism to trigger the localized production of plasmin, a 
protease that can catalyze the degradation of all components 
of the extracellular matrix, such as is needed for the endo- 
metrial  disruption  accompanying  implantation  and  early 
growth of the embryo. Interestingly, we also localized u-PA 
mRNA in the cells that are lining the maternal venous sinuses 
and which are thought to derive from the outer layer of tropho- 
blasts (Enders,  1965); as u-PA mRNA was detected in these 
cells during the development and eniargement  of venous si- 
nuses, the enzyme may play a role in preventing coagulation 
and in maintaining the patency of these vascular structures. 
The production of u-PA by trophoblast cells is in agree- 
ment with the concept of shared phenotypic similarities with 
neoplastic cells (Yagel et al.,  1988). Like trophoblasts, ma- 
lignant cells are endowed with proliferative  and migrating 
properties and have the ability to invade neighboring tissues. 
Transformed cell lines and tumors frequently produce u-PA 
(Dan~ et al.,  1985) and experimental evidence suggests that 
the enzyme is essential to their invasive properties (Ossowski 
and  Reich,  1983);  though  correlations  between  enzyme 
production and metastatic behavior have been found only in 
some cases, it has been proposed that u-PA may promote the 
metastatic dissemination of malignant cells via the dissolu- 
tion of basement membranes (Dane et al., 1985; Sappino et 
al.,  1987).  The  presence  of u-PA  mRNA  in  implanting 
trophoblasts in vivo provides novel evidence for a contribu- 
tion of the enzyme to developmental processes involving tis- 
sue destruction  and cell migration. 
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